Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled in from PubMed and updated the page revision to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:13:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:31:34.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes detected on the study details page; the core information and layout remain as previously shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:49.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-05T17:39:42.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T11:17:16.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; a Back to Top link was removed (minor UI change).
    Difference
    0.2%
    Check dated 2025-09-14T00:52:36.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.